Yu-Ting Huang

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Patrick A. Ott, Siwen Hu‐Lieskovan, Bartosz Chmielowski et al. · Cell · 2020 · 743 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Qiang Lan, Sanam Peyvandi, Nathalie Duffey et al. · Oncogene · 2018 · 134 citations · Full text

Medicine, Immunology, Oncology +17

Comparison of the Effects of Fasting Glucose, Hemoglobin A1c, and Triglyceride–Glucose Index on Cardiovascular Events in Type 2 Diabetes Mellitus

Wei‐Yu Su, Szu‐Chia Chen, Yu-Ting Huang et al. · Nutrients · 2019 · 130 citations · Full text

Medicine, Cardiology, Internal Medicine +16

CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis

Ran Liu, Huiting Wei, Peng Gao et al. · Oncotarget · 2017 · 110 citations · Full text

Life Sciences, Immunology, Oncology +17

Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine

Linping Hu, Kun Ru, Li Zhang et al. · Biomarker Research · 2014 · 101 citations · Full text

Life Sciences, Genetics, Oncology +17